April 21, 2017 / 11:29 AM / 3 months ago

BRIEF-BEIGENE INITIATES FIRST PIVOTAL STUDY IN CHINA OF PD-1 ANTIBODY BGB-A317

1 Min Read

April 21 (Reuters) - Beigene Ltd

* BEIGENE ANNOUNCES INITIATION OF FIRST PIVOTAL STUDY IN CHINA OF PD-1 ANTIBODY BGB-A317

* SAYS ALSO PLAN TO INITIATE STUDIES TO ENABLE REGULATORY APPROVAL OF BGB-A317 IN MULTIPLE GEOGRAPHIES OUTSIDE OF CHINA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below